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Effect of Coronary Stenosis Severity on Variability of Quantitative 
Arteriography, and Implications for Interventional Trials 
G. B. John Mancini, MD, Paula R. Williamson, BS, and Scott F. DeBoe, BS 
Q uantitative coronary arteriography is now routinely used in studies assessing arterial remodelling in re- 
sponse to interventions such as lipid lowering and percu- 
taneous transltinal coronary angioplasty. Although 
this methodology provides both relative and absolute 
measurements that can be evaluated statistically as con- 
tinuous variables, it is, however, often desirable or neces- 
sary to establish categorical responses to the interventions 
based on the variability inherent in the quantitative meth- 
ods (i.e., it is often necessary to state whether individual 
patients, as opposed to entire groups, have “restenosed,” 
“progressed, ” “regressed,” and so forth, and these cate- 
gorical designations are based on critical limits of vari- 
ability).lv2 These limits are generally based on an analysis 
of a rather diverse range of lesion severity, and the ques- 
tion arises as to whether the variability of measuring 
changes in lesion or segment morphology is affected by 
the initial severity of the lesion being studied. It is con- 
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ceivable that variability may be greater at 1 end than at 
the other end of the spectrum of lesion severity. If this is 
true, then the use of 1 critical value to designate whether 
a subject has responded in a certain way would be inap 
propriate, and this designation would be better achieved 
by using criteria that more directly reflect the measure- 
ment variability of lesions of a specified, initial severity. 
This report examines whether the variability of measur- 
ing morphologic parameters of stenoses is affected by the 
baseline severity of the lesion. 
Records of digitally archived cineangiographic im- 
age frames (1 view) of narrowings previously acquired 
were retrospectively reviewed to establish a data set of 50 
lesions distributed evenly among 5 categories of percent 
diameter stenosis severity (0 to 20,21 to 40,41 to 60,61 
to 80, and 81 to 99%). One technician retrieved these 
images and reanalyzed them without knowledge of the 
originally determined stenosis severity. These images 
were then reanalyzed at an interval of 21 week (mean 2 
weeks) by the same technician without knowledge of the 
prior results. Each analysis consisted of an assessment 
of the minimum, maximum and mean diameter of the 
segment, as well as percent diameter stenosis.3 Within 
lA6l.E I Variability of Minimum, Maximum and Mean Diameters, and Percent Diameter 
Stenosis as a Function of Initial Percent Diameter Coronary Stenosis Severity 
Initial Severity 
0 to 20% 21 to 40% 41 to 60% 61 to 80% 81 to 99% All 
Minimum diameter (mm) 
Mean 2.4 f 0.7 1.9 2 0.4 1.6 f 0.3 1.3 f 0.4 0.4 + 0.3 1.5 2 0.8 
Range 1.3-4.0 1.2-2.5 1.2-2.4 0.7-1.9 0.1-1.1 0.1-4.0 
Accuracy 0.03 0.01 0.00 -0.02 -0.01 0.00 
Precision 0.12 0.13 0.13 0.05 0.14 0.11 
Mean absolute difference 0.09 0.09 0.11 0.04 0.10 0.10 
r value 0.99 0.94 0.95 0.99 0.89 0.99 
Maximum diameter (mm) 
Mean 3.120.7 3.220.6 3.550.7 4.0+1.1 3.121.3 3.4kl.O 
Range 1.8-4.6 2.1-4.2 2.2-4.5 2.7-6.2 1.5-6.1 1.5-6.2 
Accuracy 0.13 -0.04 0.00 -0.20 -0.03 -0.03 
Precision 0.20 0.31 0.22 0.21 0.24 0.25 
Mean absolute difference 0.18 0.23 0.17 0.24 0.17 0.20 
r value 0.97 0.91 0.96 0.98 0.98 0.97 
Mean diameter (mm) 
Mean 2.7 + 0.7 2.4 f 0.4 2.4 -c 0.4 2.7 ZL 0.8 1.9 t 0.9 2.4 + 0.7 
Range 1.6-4.4 1.6-3.3 1.7-3.3 1.6-4.5 0.94.3 0.9-4.5 
Accuracy 0.04 -0.01 0.07 -0.10 0.00 0.00 
Precision 0.11 0.16 0.13 0.11 0.20 0.15 
Mean absolute difference 0.08 0.13 0.12 0.11 0.15 0.12 
r value 0.99 0.94 0.97 0.99 0.98 0.98 
Percent diameter stenosis 
Mean 15 2 4 34 t 5 51 2 6 66 2 4 85 f 4 50 + 25 
Range 6-20 20-39 43-59 61-73 81-93 693 
Accuracy -1.7 -2.0 -0.5 -0.9 0.1 -1.0 
Precision 2.1 4.4 2.8 1.7 2.8 2.9 
Mean absolute difference 2.2 4.0’ 2.2 1.4* 2.3 2.4 
r value 0.86 0.65 0.89 0.93 0.74 0.99 
2 < O.O1. can values + SD. NO accuracy value is significantly different from 0. 
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each severity subgroup and for each anatomic measure- 
ment, correlation coefficient (r value), accuracy (mean 
differences between the 2 measurements, retaining the 
direction of the difference), precision (standard devi- 
ation of mean differences) and mean absolute difference 
(mean absolute difference between measurements; i.e., 
direction of the difference was ignored) were calculated. 
For these analyses, the first set of measurements was 
considered the standard by which the second set was 
compared. In contrast to other reportq2 this study re- 
flects only the variability that can be ascribed to baseline 
lesion severity and does not include the increased vari- 
ability that can be expected when frame reselection and 
redigitization are involved. 
Correlation coefficients were assessed using a Bon- 
ferroni-adjusted Fisher’s Z transformation. Repeated 
measures analysis of variance was used for assessing 
accuracy and mean absolute difference values. In the 
case of mean absolute differences, a Newman-Keuls si- 
multaneous comparisons test was used to determine 
which subgroups were significantly different. Precision 
was assessed using a Hartley test for heterogeneous vari- 
ances. Results were considered significant at p cO.05. 
Table Z shows the study results and includes an as- 
sessment of the overall variability in the entire cohort. 
There were no significant differences among any of the 
absolute measures of stenosis severity. The mean abso- 
lute difference of the percent diameter stenosis parame- 
ter was higher in the 21 to 40% severity group than in the 
61 to 80% one (4.0 f 2.4% us 1.4 f 1.1%; p <O.Ol). 
These 2 values were not significantly different from any 
of the other mean absolute difference values (range 2.2 
to 2.4%) in the other subgroups. 
This study demonstrates that the variability of abso- 
lute stenosis dimensions is not significantly affected by 
the initial severity of the stenosis being measured. The 
percent diameter stenosis measurement showed a minor 
tendency to be more variable in the modest (21 to 40%) 
than in a more severe (61 to 80%) group. This was mani- 
fest as a statistically significant difference in the mean 
absolute difference in repeated measures and was sup- 
ported by a lower (although not significantly) correlation 
coefficient. Therefore, this study suggests that 1 categori- 
cal criterion can be used to assess responses to therapy 
and intervention, which are not affected by the initial 
severity of the lesion when absolute measurements are 
used. For most purposes, the same probably applies to 
measures of percent diameter stenosis. However, it may 
be prudent for investigators interested in following a par- 
ticular subset of stenoses (e.g., “new lesion formation”) to 
create quantitative limits for categoric determinations 
based specifically on the range of severity of the type of 
lesion to be investigated.4 
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Coronary Artery Disease and Factor VII Hyperactivity in Elderly 
Japanese 
Kazuomi Kario, MD, Takefumi Matsuo, MD 
H igh levels of factor VII (FVII) coagulant activity (FVIIc) have been associated with an increased risk 
of coronary artery disease and cardiac death, and are 
thought to be of greater significance than cholesterol in 
the first 5 years after screening.’ These studies have 
mainly been performed in Western countries and the 
subjects were generally adults aged <65 years. Japan is 
one of the countries where the incidence of coronary 
artery disease is 10w,~ and we have recently reported on 
FVII hyperactivity in the elderly Japanese.3 This time, to 
study the relation between coronary artery disease and 
FVII in elderly Japanese persons, we performed electro- 
cardiography and measured FVIIc and FVII antigen 
(FVIIag) levels as well as blood lipid fractions. 
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A total of 317 elderly Japanese subjects (>60 years 
old), who were residents of a local home for the aged, 
were studied. Fifty-one of the 127 subjects (40%) with 
hypertension ana’ 27 of the 37 subjects (73%) with diabe- 
tes mellitus were receiving medication. Eighteen subjects 
received antihyperlipidemic agents. An electrocardio- 
gram was recorded in all subjects. Subjects who did not 
have hypertension, diabetes mellitus, peripheral vascu- 
lar disease, hyperlipidemia, a history of stroke, or an 
ischemic electrocardiographic tracing were classified as 
the healthy elderly group (82 men, mean age 77 f 9 
years; 62 women, mean age 80 f 7 years). Blood samples 
were collected after a 12-hour fast. FVZZc was assayed 
by an automated l-stage method (Coag-stat, Kyoto 
Daiichi Pharmacological Co.), using human FVZZ-defy- 
cienl plasma (Dade, France) and rabbit calcified throm- 
boplastin reagent (Thromboplastin C, Dade, France). 
FVZZag was, assayed by an ELZSA (Diagnostica Stago, 
France). In briefi diluted plasma samples or calibulators 
(normal plasma pool of 20 nonsmoking men aged <30 
years) were added to the microwells that had been coated 
BRIEF REPORTS 807 
